Helix

Founded in 2015, Helix is a leader in population genomics, focused on accelerating the integration of genomic information into patient care. The company partners with health systems, life sciences companies, and payers to implement large-scale genomic screening and research programs. By using its proprietary Exome+® sequencing technology and its end-to-end platform, Helix helps to identify individuals at risk for preventable genetic conditions, enabling early intervention and advancing personalized medicine. Their mission is to empower every person to improve their life through DNA.